APA

Alhan C., Westers T. M., van der Helm L. H., Eeltink C., Huls G., Witte B. I., Buchi F., Santini V., Ossenkoppele G. J. & van de Loosdrecht A. A. (20141125). Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. : Cytometry. Part B, Clinical cytometry.

Chicago

Alhan Canan, Westers Theresia M, van der Helm Lieke H, Eeltink Corien, Huls Gerwin, Witte Birgit I, Buchi Francesca, Santini Valeria, Ossenkoppele Gert J and van de Loosdrecht Arjan A. 20141125. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. : Cytometry. Part B, Clinical cytometry.

Harvard

Alhan C., Westers T. M., van der Helm L. H., Eeltink C., Huls G., Witte B. I., Buchi F., Santini V., Ossenkoppele G. J. and van de Loosdrecht A. A. (20141125). Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. : Cytometry. Part B, Clinical cytometry.

MLA

Alhan Canan, Westers Theresia M, van der Helm Lieke H, Eeltink Corien, Huls Gerwin, Witte Birgit I, Buchi Francesca, Santini Valeria, Ossenkoppele Gert J and van de Loosdrecht Arjan A. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes. : Cytometry. Part B, Clinical cytometry. 20141125.